Synapse Open Synapse
Biology

Rapid target engagement of KRAS G12C tricomplex inhibitor RO3903 overcomes resistance and drives durable tumor regression

PNAS ·

Proceedings of the National Academy of Sciences, Volume 123, Issue 45, November 2026. SignificanceTransient target coverage enables oncogenic variants to cycle into drug-insensitive conformations, fueling adaptive resistance in precision oncology.

Latest from PNAS